The Collier Report of U.S. Government Contracting

Old School Reporting Using Modern Technology

Cellectis Bioresearch Inc

Sampling of Federal Government Funding Actions/Set Asides

In order by amount of set aside monies.

  • $594,300 - Monday the 24th of September 2012
    National Institutes Of Health
    NIH, NHLBI, DERA OA OFC ACQUISTIONS
    CELLECTIS BIORESEARCH INC.:1196591 [12-006520]
  • $5,090 - Saturday the 1st of December 2012
    National Institutes Of Health
    NIH, NICHD, OD OAM OFC ADMIN MGMT
    IGF::OT::IGF OTHER FUNCTIONS; TALENA SURE KOA : DESIGN, ENGINEERING AND DELIVERY OF A TALENA SURE KOA CLEAVING CUSTOMERS EPISOMAL TARGET SEQUENCE, FOR GENE KNOCKOUT PURPOSES. CATALOG#: TALEN-SKO-RUO
  • $5,090 - Thursday the 9th of February 2012
    National Institutes Of Health
    NIH, NICHD, OD OAM OFC ADMIN MGMT
    DESIGNING AND ENGINEERING OF TALEN SURE KO CUSTOM REAGENT
  • $199,500 - Friday the 13th of December 2013
    National Institutes Of Health
    NIH, NHLBI, DERA OA OFC ACQUISTIONS
    IGF::OT::IGF DESIGN, ENGINEERING, AND DELIVERY, OF A CUSTOM TALEN CLEAVING NIH-CRM'S EPISOMAL TARGET SEQUENCE. DESIGN AND GENERATION OF EPISOMAL TARGET SEQUENCE PLASMID, CLONING OF EACH TALAEN UNIT IN YEAST EXPRESSION VECTOR, AND MEASUREMENT OF CLEAVAGE RATE BY YEAST SINGLE STRAND ANNEALING (SSA) ASSAY.
  • $10,000 - Wednesday the 29th of January 2014
    Food And Drug Administration
    DEPT OF HHS/FOOD AND DRUG ADMINISTRATION
    IGF::OT::IGF OTHER FUNCTIONS-GENE SEQUENCING SERVICES

© Copyright 2019
The Collier Report
published by 1918 Media LLC.
Information displayed in this dossier has been provided through available open source or public sources. No reliance should be made by readers or Collier Report subscribers. Funding actions are complicated and do not always represent dollar-for-dollar payments to vendors nor do they represent payments in certain instances. Requests for the modification of displayed information may be made to help.desk@1918.media.